Foot-and-mouth disease: reaction of convalescente pigs to homologous virus exposure
Data
1977ISSN
0009-0131
Metadata
Mostrar registro completoResumo
Pigs are more difficult to protect against foot-and-mouth disease (FMD) with inactivated virus vaccines than cattle or sheep (4, 6, 7). Also the results of exposure of convalescent pigs to homologous FMD virus have been variable. Cunliffe (2) studied the antibody level of FMD convalescent pigs and re-exposed them to the homologous virus 28 days or 128 days after the initial infection, respectively. Only one of 10 pigs of the last group became clinically ill at re=exposure. How-ever, McKercher and Giordano (8) reported that at re-exposure, from 12 convalescent pigs (90-180 days after infection), 6 showed lesions on the snout or on one or more feet. These authors used contact exposure with FMD-infected pigs as a mean of re-exposure, since this method was considered the one by which pigs would naturally be infected.
Cita
Gomes I. Foot-and-mouth disease: reaction of convalescente pigs to homologous virus exposure. Bol Cent Panam Fiebre Aftosa. 1977; 26: 19-22.
Collections
Itens relacionados
Apresentado os itens relacionados pelo título, autor e assunto.
-
Doel, T. R.; Kanashiro, M. M.; Silva, J. L. (OPSBrazilRio de Janeiro, 1993)La mayoría de los anticuerpos monoclonales (AcMs) desarrollados contra las cepas O1 Campos, A24 Cruzeiro y C Indaial de la fiebre aftosa y que previamente mostraron reacción con el VP1 en "Western Blots", reconocieron ...
-
Sutmöller, P; Vieira, A (OPSBrazilRio de Janeiro, 1980)Mediante la prueba de seroneutralización en tubo, en el Centro Panamericano de Fiebre Aftosa (CPFA) se examinaron sueros sanguíneos de 791 bovinos vacunados y expuestos al virus de la fiebre aftosa (FA). Como sistema para ...
-
Silva, J. L.; Kanashiro, M. M.; Brum, D. L. (OPSBrazilRio de Janeiro, 1993)Se describen los anticuerpos monoclonales (AcMs) producidos contra los virus de la fiebre aftosa tipo O, A y C. Para la caracterización preliminar se utilizaron las pruebas de virus-neutralización y seroprotección, y para ...